Therapy with a non-blocking monoclonal antibody targeting soluble NKG2D ligand MIC revamps endogenous innate and adaptive anti-tumor responses and eliminates primary and metastatic tumors

被引：0
|
作者：
Wu, Jennifer [1 ]
机构：
[1] Med Univ S Carolina, Charleston, SC 29425 USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2016年 / 4卷 / 01期
关键词：
D O I：
10.1158/2326-6074.CRICIMTEATIAACR15-A053
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A053
引用
收藏
页数：1
相关论文
共 12 条
  • [1] Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors
    Lu, Shengjun
    Zhang, Jinyu
    Liu, Dai
    Li, Guangfu
    Staveley-O'Carroll, Kevin F.
    Li, Zihai
    Wu, Jennifer D.
    CLINICAL CANCER RESEARCH, 2015, 21 (21) : 4819 - 4830
  • [2] Delivery of NKG2D Ligand Using an Anti-HER2 Antibody-NKG2D Ligand Fusion Protein Results in an Enhanced Innate and Adaptive Anti-Tumor Response.
    Shin, S-U
    Cho, H-M
    Tolba, K.
    Shin, S. J.
    Shin, D. S.
    Calfa, C.
    Zhang, Y.
    Rosenblatt, J. D.
    CANCER RESEARCH, 2009, 69 (24) : 857S - 857S
  • [3] Cooperative anti-tumor effect of soluble NKG2D ligand MIC neutralization and PD-1 pathway blockade
    Basher, Fahmin
    Wu, Jennifer
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [4] Antibody targeting soluble NKG2D ligand sMIC induces regression of primary tumors and eliminates metastasis in multiple pre-clinical cancer models
    Wu, Jennifer D.
    Basher, Fahmin
    Rubinstein, Mark
    CANCER RESEARCH, 2015, 75
  • [5] Antibody targeting soluble NKG2D ligand sMIC sensitizes metastatic prostate tumor and other MIC+ tumors to PD1/PD-L1 blockade therapy in pre-clinical models
    Wu, Jennifer D.
    Zhang, Jinyu
    Larrocha, Pablo
    Dhar, Payal
    CANCER RESEARCH, 2019, 79 (13)
  • [6] Cooperative therapeutic anti-tumor effect of IL-15 agonist ALT-803 and co-targeting soluble NKG2D ligand sMIC
    Basher, Fahmin
    Jeng, Emily K.
    Wong, Hing
    Wu, Jennifer
    ONCOTARGET, 2016, 7 (01) : 814 - 830
  • [7] D02, a novel, non-blocking antibody targeting IL2RA, exhibits significant anti-tumor activity in IL2RA-humanized mice
    Cao, Shuzhen
    Zhang, Wenjiao
    Lin, Qingcong
    CANCER RESEARCH, 2023, 83 (07)
  • [8] Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy
    Basher, Fahmin
    Dhar, Payal
    Wang, Xin
    Wainwright, Derek A.
    Zhang, Bin
    Sosman, Jeffrey
    Ji, Zhe
    Wu, Jennifer D.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [9] Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy
    Fahmin Basher
    Payal Dhar
    Xin Wang
    Derek A. Wainwright
    Bin Zhang
    Jeffrey Sosman
    Zhe Ji
    Jennifer D. Wu
    Journal of Hematology & Oncology, 13
  • [10] Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual costimulation of CD8 T cells and enables sMIC plus tumors to respond to PD1/PD-L1 blockade therapy.
    Zhang, Jinyu
    Larrocha, Pablo
    Dhar, Payal
    Wu, Jennifer
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 70 - 70
12